🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase I vaccination trial in patients suffering from recently diagnosed m...
Status
Completed
Location
University Hospital Erlangen Dept. of Dermatology
Start Date
2020-09-24
Trial ID
NCT04335890
Treatments Being Tested
RATIONALE: Vaccines made from a patient's white blood cells (dendritic cell...
Status
Completed
Location
Antwerp University Hospital/Center for Cellular Therapy and Regenerative Medicine
Start Date
2005-03
Trial ID
NCT00834002
Treatments Being Tested
In prior trials of CMV RNA-pulsed dendritic cell vaccines, there has been a...
Status
Terminated
Location
University of Florida Health Shands Hospital
Start Date
2022-01-13
Trial ID
NCT04963413
Dendritic cells (DCs) are the professional antigen-presenting cells of the ...
Status
Completed
Location
Radboud University Nijmegen Medical Center, dept. of Medical Oncology
Start Date
2003-12
Trial ID
NCT00228189
Treatments Being Tested
This trial proposes to evaluate the immunologic and potential clinical effe...
Status
Not Yet Recruiting
Location
UMPC Hillman Cancer Center
Start Date
2026-08
Trial ID
NCT07634094
Treatments Being Tested
Transfection with siRNA targeting the immunoproteasome alters proteasome-me...
Status
Completed
Location
Duke University Medical Center
Start Date
2008-01
Trial ID
NCT00672542
Treatments Being Tested
RATIONALE: Vaccines made from a person's dendritic cells and antigens may m...
Status
Completed
Location
Dermatologische Klinik mit Poliklinik - Universitaetsklinikum Erlangen
Start Date
2003-07
Trial ID
NCT00074230
Treatments Being Tested
To find the highest tolerable dose of an mRNA vaccine that can be safely gi...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-03-22
Trial ID
NCT05799612
The purpose of this trial is to examine the safety, feasibility, immunologi...
Status
Completed
Location
University of California - Irvine
Start Date
2004-01
Trial ID
NCT00087984
Treatments Being Tested
Dendritic cells (DCs)are the most potent antigen-presenting cells of the im...
Status
Completed
Location
Radboud University Nijmegen Medical Center
Start Date
2004-04
Trial ID
NCT00243529
Treatments Being Tested